Durability of radiofrequency ablation in Barrett's esophagus with dysplasia.
暂无分享,去创建一个
Hiroshi Mashimo | Amitabh Chak | Bergein F Overholt | Herbert C Wolfsen | Prateek Sharma | Kenneth J. Chang | Robert H Hawes | Nicholas J Shaheen | J. Hunter | B. Overholt | Kenneth K Wang | C. Lightdale | M. Kimmey | M. Bronner | J. Goldblum | A. Chak | R. Sampliner | H. Mashimo | R. Hawes | B. Hoffman | D. Fleischer | V. Sharma | H. Wolfsen | Prateek Sharma | N. Shaheen | J. Galanko | G. Falk | R. Rothstein | A. Peery | S. Spechler | R. Souza | S. Gordon | A. Siddiqui | S. Edmundowicz | R. Madanick | G. Eisen | M. Fennerty | B. Jobe | John R Goldblum | Richard E Sampliner | David E Fleischer | Joseph A Galanko | Rhonda F Souza | Mary P Bronner | Virender K Sharma | A. Bennett | V. Muthusamy | A. Infantolino | M Brian Fennerty | Michael B Kimmey | Gary W Falk | Brenda J Hoffman | Steven A Edmundowicz | Kenneth J Chang | Charles J Lightdale | Glenn M Eisen | John G Hunter | Ana E Bennett | Richard I Rothstein | Stuart R Gordon | Ryan D Madanick | Anne F Peery | V Raman Muthusamy | Stuart J Spechler | Ali A Siddiqui | Anthony Infantolino | John A Dumot | Blair A Jobe | J. Dumot | David E. Fleischer | Kenneth K. Wang | Gary W. Falk | N. Shaheen | Robert H. Hawes | Kenneth J. Chang | Stuart R. Gordon | Virender K. Sharma | Glenn M. Eisen | John G. Hunter | Ana E. Bennett | Ali A. Siddiqui
[1] Paul Fockens,et al. Efficacy of radiofrequency ablation combined with endoscopic resection for barrett's esophagus with early neoplasia. , 2010, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[2] P. Mavrelis,et al. Radiofrequency ablation of Barrett’s esophagus: outcomes of 429 patients from a multicenter community practice registry , 2010, Endoscopy.
[3] G. Triadafilopoulos,et al. Efficacy of esomeprazole in controlling reflux symptoms, intraesophageal, and intragastric pH in patients with Barrett's esophagus. , 2003, Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus.
[4] Amy Linsky,et al. Proton pump inhibitors and risk for recurrent Clostridium difficile infection. , 2010, Archives of internal medicine.
[5] Kenneth K Wang,et al. Updated Guidelines 2008 for the Diagnosis, Surveillance and Therapy of Barrett's Esophagus , 1998, The American Journal of Gastroenterology.
[6] S. Hennessy,et al. Proton-Pump Inhibitor Use and the Risk for Community-Acquired Pneumonia , 2008, Annals of Internal Medicine.
[7] N. Soehendra,et al. Stepwise radical endoscopic resection versus radiofrequency ablation for Barrett's oesophagus with high-grade dysplasia or early cancer: a multicentre randomised trial , 2011, Gut.
[8] Ananya Das,et al. Circumferential and Focal Ablation of Barrett's Esophagus Containing Dysplasia , 2009, The American Journal of Gastroenterology.
[9] A. Sonnenberg,et al. Long-term nonsurgical management of Barrett's esophagus with high-grade dysplasia. , 2001, Gastroenterology.
[10] D. Corley,et al. Proton pump inhibitors and histamine-2 receptor antagonists are associated with hip fractures among at-risk patients. , 2010, Gastroenterology.
[11] S. Suissa,et al. Proton pump inhibitor use and risk of community-acquired Clostridium difficile-associated disease defined by prescription for oral vancomycin therapy , 2006, Canadian Medical Association Journal.
[12] Kenneth K Wang,et al. Long-term survival following endoscopic and surgical treatment of high-grade dysplasia in Barrett's esophagus. , 2007, Gastroenterology.
[13] Michael D Howell,et al. Acid-suppressive medication use and the risk for hospital-acquired pneumonia. , 2009, JAMA.
[14] G. Triadafilopoulos,et al. Oesophageal and gastric pH profiles in patients with gastro‐oesophageal reflux disease and Barrett's oesophagus treated with proton pump inhibitors , 2004, Alimentary pharmacology & therapeutics.
[15] D. Fleischer,et al. A prospective pilot trial of ablation of Barrett's esophagus with low-grade dysplasia using stepwise circumferential and focal ablation (HALO system). , 2008, Endoscopy.
[16] P. Fockens,et al. Eradication of Barrett Esophagus with Early Neoplasia by Radiofrequency Ablation, with or without Endoscopic Resection , 2008, Journal of Gastrointestinal Surgery.
[17] Yu-Xiao Yang,et al. Long-term proton pump inhibitor therapy and risk of hip fracture. , 2006, JAMA.
[18] P. Fockens,et al. Stepwise circumferential and focal ablation of Barrett’s esophagus with high-grade dysplasia: results of the first prospective series of 11 patients , 2008, Endoscopy.
[19] J K Greenson,et al. Reproducibility of the diagnosis of dysplasia in Barrett esophagus: a reaffirmation. , 2001, Human pathology.
[20] N. Shaheen,et al. A cost-utility analysis of ablative therapy for Barrett's esophagus. , 2009, Gastroenterology.
[21] R. K. Pearson. Radiofrequency Ablation in Barrett's Esophagus with Dysplasia , 2009 .
[22] Kenneth J. Chang,et al. Circumferential ablation of Barrett's esophagus that contains high-grade dysplasia: a U.S. Multicenter Registry. , 2008, Gastrointestinal endoscopy.
[23] Kenneth J. Chang,et al. Endoscopic radiofrequency ablation for Barrett’s esophagus: 5-year outcomes from a prospective multicenter trial* , 2010, Endoscopy.
[24] P. Fockens,et al. What Are the Outcomes of Endoscopic Radiofrequency Ablation for Very Long Segments of Barrett Esophagus Containing Neoplasia , 2009 .
[25] M. Vieth,et al. Properties of the Neosquamous Epithelium After Radiofrequency Ablation of Barrett's Esophagus Containing Neoplasia , 2009, The American Journal of Gastroenterology.